T cell protection
T cells from common colds cross-protect against infection with SARS-CoV-2
People with higher levels of T cells from common cold coronaviruses are less likely to become infected with SARS-CoV-2.
Stories tagged with 'vaccines'
Most popular stories 2021
The ten most popular Imperial news stories of 2021
Well into the second year of the COVID-19 pandemic Imperial research continues to save lives and generate headlines around the world.
Real-world vaccine data
Real-world data provides valuable insights into COVID vaccine roll-out
Analysis of Europe’s largest patient data record has provided valuable insights into the UK’s COVID-19 vaccine roll-out, an Imperial expert has said.
COVID-19 symposium
COVID-19 experts from Imperial and Singapore share lessons from pandemic
Scientists from the UK and Singapore have come together to discuss their research during the COVID-19 pandemic at an online symposium.
Feature
Covid on the continent
How African countries are dealing with the COVID-19 pandemic
We take a deep dive into how three African nations have dealt with the pandemic so far, and how they are rolling out vaccine programmes.
Omicron update
Omicron - latest findings and commentary from Imperial experts
Experts from Imperial College London and worldwide are working around the clock to understand the rapidly spreading Omicron variant of COVID-19.
News in brief
COVID immunity study and green league ranking: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Funding frontier research
Boundary-pushing research projects boosted by President’s Excellence Fund
Projects making nanomagnetic computers, sustainable packaging, improved vaccine carriers, and cut-and-paste chemistry have won up to £250k each.
COVID-19 IMMUNE IMPRINT
Immune imprinting causes varied patterns of protection against COVID-19 variants
Research shows that the first SARS-CoV-2 spike protein a person encounters, be it by vaccination or infection, shapes their subsequent immune response
Omicron Insights
Q&A: Imperial experts discuss new variant Omicron
What is the new variant, how is it different, and how concerned should we be?
3
